CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
4.9 (356) · € 35.99 · En Stock
Nasdaq Sees IPOs Emerging If Market Holds Before U.S. Election - Bloomberg
Temasek-Backed UST Seeks to Raise at Least $500 Million in IPO - Bloomberg
Bladder Cancer Therapies Developer Raises $380M in the First Biotech IPO of 2024 - MedCity News
A Record Year for IPOs in 2021
CG Oncology, Inc. (CGON) Stock Price, Quote & News - Stock Analysis
Celebrating Listings & Milestone Moments at Nasdaq in 2023
CG Oncology IPO Soars 96% on Day 1 - Orange County Business Journal
424B4
IPO Tracker - Life Sciences Perspectives
Our Take: Financial distress fueled increase in hospital and health system M&A activity in 2023, report indicates
A Record Pace for IPOs
CG Oncology brings in $380M from first biotech IPO of 2023
